Article
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model.
mBio - 2 Mar 2021
Amanat Fatima, Strohmeier Shirin, Rathnasinghe Raveen, Schotsaert Michael, Coughlan Lynda, García-Sastre Adolfo, Krammer Florian
Abstract excerpt
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the prime target for vaccine development. The spike protein mediates both binding to host cells and membrane fusion and is also so far the only known viral target of neutralizing antibodies. Coronavirus spike proteins are large trimers that are relatively unstable, a feature that might be enhanced by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
